Table 4.
Genotype | n (total) | n (hospitalisation) (%) | Odds ratio | p | n (death) (%) | Odds ratio | p |
---|---|---|---|---|---|---|---|
G0/G0 | 2853 | 54 (1.9%) | 1.0 (ref) | 14 (0.5%) | 1.0 (ref) | ||
G0/G1 | 2273 | 49 (2.2%) | 1.1 (0.7–1.6) | 0.72 | 12 (0.5%) | 1.3 (0.6–2.9) | 0.54 |
G0/G2 | 1219 | 23 (1.9%) | 1.0 (0.6–1.6) | 0.87 | 5 (0.4%) | 1.0 (0.3–2.6) | 0.99 |
G1/G1 | 644 | 11 (1.7%) | 0.8 (0.4–1.6) | 0.58 | 2 (0.3%) | 0.9 (0.2–3.3) | 0.93 |
G1/G2 | 320 | 15 (4.7%) | 2.3 (1.2–4.1) | 0.01 | 8 (2.5%) | 6.6 (2.5–16.7) | 0.0003 |
G2/G2 | 153 | 2 (1.3%) | 0.8 (0.2–2.4) | 0.74 | 1 (0.7%) | 2.4 (0.3–10.1) | 0.38 |
p values < 0.05 are shown in bold. The G1/G2 genotype was associated with hospitalisation and death as a result of a COVID-19.